Abstract: OBJECTIVE To compare the effects and costs of three new vasodilators(vinpocetine;buflomedil;cinepazide)combined with ozagrel in treating acute cerebral infarction(ACI).METHODS Cost-minimization analysis(CMA)of pharmacoeconomics was applied to analyze the